Omics-based Clinical Trials Market Summary
The global omics-based clinical trials market was valued at USD 32.64 billion in 2024 and is anticipated to reach USD 51.77 billion by 2030, expanding at a compound annual growth rate (CAGR) of 8.02% from 2025 to 2030. The market growth is primarily driven by rapid advancements in omics technologies, the rising demand for personalized...
Deutsch 
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek